.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Lars Lindner

Munich / DE

University of Munich

Vorsitz

08.11.2024
11:00 – 12:30
Scientific session
Nanotechnology and hyperthermia
Auditorium (Aula magna)

Vortrag

06.11.2024
09:00 – 09:40 40 Min. 0 Min.
Oral Presentation
Thermosensitive liposomes
07.11.2024
16:29 – 16:41 9 Min. 3 Min.
Oral Presentation
OP-28
Phase I study of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma
Hyperthermia clinical applications: radio-chemo-immunotherapy

Weitere Beteiligungen

07.11.2024
15:24 – 15:26 2 Min. 0 Min.
Flash Presentation
FP-22
Hazard of biliary stent heating in radiative deep regional hyperthermia (RHT)
Q&A: thermometry, treatment planning, image guide
07.11.2024
16:29 – 16:41 9 Min. 3 Min.
Oral Presentation
OP-28
Phase I study of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma
Hyperthermia clinical applications: radio-chemo-immunotherapy
08.11.2024
09:56 – 10:08 9 Min. 3 Min.
Oral Presentation
OP-32
A randomized phase III trial comparing trabectedin to trabectedin combined with regional hyperthermia in patients with pre-treated soft tissue sarcoma: HyperTET a German Interdisciplinary Sarcoma Group (GISG) trial
Hyperthermia clinical applications: radio-chemo-immunotherapy
08.11.2024
11:32 – 11:44 9 Min. 3 Min.
Oral Presentation
OP-43
Evaluation of magnetic resonance thermometry performance during MR-guided hyperthermia treatment of soft-tissue sarcoma in the pelvis and lower extremities
Q&A: thermometry, treatment planning, image guide